Abstract: Objective To analyze the financial burden of pulmonary tuberculosis patients under different management model. Methods Randomized stratified clustered sampling method was used to select 419 tuberculosis pulmonary cases in 16 sample counties,and questionnaire was used to collect data of the patients under different management models.Economic evaluation method was used to analyze the financial burden of pulmonary tuberculosis patients. Results The average financial burden of pulmonary tuberculosis patients was 3842 yuan.Under three different management modes the financial burden were 3319 yuan,4031 yuan and 4271 yuan respectively.There was no significant difference among the different management models.However,there was significant difference in different areas under three different management odels(F=3.8,P<0.05). The ratio of disease expenditure to the net income of the patient was 94.1%,the ratios of disease expenditure to the net income of the patient’s family was 64.8%.The proportion of expenditure of hospitalization listed as the biggest expenditure in the financial burden of pulmonary tuberculosis patients was 22.4%.Among the three management models,expenditure of hospitalization was the biggest expenditure in the financial burden of pulmonary tuberculosis patients,followed by the expenditure on drugs to protect liver function.The average financial burden of pulmonary tuberculosis patients treated in general hospital was higher than it in center for disease control and prevention(F=7.5,P<0.05).The free supplies provided by government accounted for 17.2% among the financial burden averagely and the patients paid,83.0% of the financial burden themselves. Conclusions The financial burden of pulmonary tuberculosis patients was high. In order to reduce the financial burden of pulmonary tuberculosis patients,the government should increase the input to TB control and meanwhile strictly control the rate of hospitalization,the expenditure of hospitalization and expenditure on the assistant durg.

Key words: Pulmonary tuberculosis/economics